Skip to main content

Table 2 Mortality in patients with and without DM in different patients subgroups

From: Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic

 

Factor present

 

Yes

No

 

DM

Non-DM

P value

DM

Non-DM

P value

Age > 80 (%)

7.5

3.8

0.071

1.5

0.3

0.006

Female gender (%)

5.0

1.2

0.001

2.0

0.9

0.098

Hypertension (%)

3.3

1.1

0.003

0.0

0.7

0.362

Hypercholesterolemia (%)

3.3

1.2

0.012

1.5

0.7

0.378

Smoking (%)

1.0

0.2

0.262

3.4

1.2

0.004

Chronic renal failure (%)

9.9

2.8

0.036

2.0

0.9

0.044

Peripheral artery disease (%)

3.1

3.1

1.000

3.0

0.8

 < 0.001

Previous CAD (%)

2.4

1.8

0.537

3.0

0.7

0.001

Previous infarction (%)

2.4

0.6

0.314

3.1

1.1

0.002

Previous PCI (%)

2.4

0.4

0.165

3.2

1.1

0.003

Previous CABG (%)

0.0

6.3

0.242

3.2

0.9

 < 0.001

Previous valve replacement (%)

4.3

1.5

0.444

2.6

0.8

0.002

Left ventricular dysfunction (%)

1.6

0.7

0.370

3.2

1.0

0.001

NYHA > 2 (%)

7.1

2.5

0.061

2.1

0.7

0.014

CCS > 2 (%)

4.8

3.9

1.000

2.7

0.7

0.001

  1. PC Percutaneous coronary intervention. CABG Coronary artery bypass grafting, NYHA New York Heart Association, CCS Cardiology Canadian Society